Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019

Binding levels and neutralization activity of anti–type 1 interferon autoantibodies peaked during acute coronavirus disease 2019 and markedly decreased thereafter. Most patients maintained some ability to neutralize type 1 interferon into convalescence despite lower levels of binding immunoglobulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, Elana R, Rosen, Lindsey B, Cheng, Aristine, Dobbs, Kerry, Delmonte, Ottavia M, Ferré, Elise M N, Schmitt, Monica M, Imberti, Luisa, Quaresima, Virginia, Lionakis, Michail S, Notarangelo, Luigi D, Holland, Steven M, Su, Helen C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689695/
https://www.ncbi.nlm.nih.gov/pubmed/34875033
http://dx.doi.org/10.1093/cid/ciab1002
Descripción
Sumario:Binding levels and neutralization activity of anti–type 1 interferon autoantibodies peaked during acute coronavirus disease 2019 and markedly decreased thereafter. Most patients maintained some ability to neutralize type 1 interferon into convalescence despite lower levels of binding immunoglobulin G. Identifying these autoantibodies in healthy individuals before the development of critical viral disease may be challenging.

Ejemplares similares